We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
How is Under Armour (UAA) Stock Placed Ahead of Q1 Earnings?
Read MoreHide Full Article
Under Armour, Inc. (UAA - Free Report) is scheduled to report first-quarter 2018 results on May 1, before the opening bell.
The question lingering in investors’ minds is whether this marketer and distributor of apparel, footwear and accessories will be able to deliver a positive earnings surprise in the quarter to be reported. Let’s see how things are shaping up prior to this announcement.
What to Expect?
The Zacks Consensus Estimate for the quarter is pegged at a loss of 5 cents, wider than the loss of a penny reported a year ago. Analysts polled by Zacks expect revenues of $1.12 billion, almost flat with the year-ago quarter figure.
Under Armour, Inc. Price, Consensus and EPS Surprise
For the first quarter, management expects revenues to decline or remain flat in comparison to the year-ago quarter. Further, the company envisions loss per share in the range 6-7 cents on the back of adjusted operating loss of nearly $15 million.
We believe that the prolonged weakness in the North American business is likely to tarnish first-quarter results. The company has been reporting sluggish sales from the region since fourth-quarter 2016. In fourth-quarter 2017, sales in North America declined 4.5%. The dismal show can be attributed to bankruptcies, store closures, decreased productivity and demand along with shift in fashion preference.
Additionally, gross margin has been consistently shrinking in the past few quarters. In fourth-quarter 2017, the metric contracted 140 basis points (bps) to 45% following a decline of 130, 190 and 70 bps in the third, second and first quarter, respectively. Management expectsgross margin to remain flat in the first quarter of 2018.
Further, Under Armour has been struggling to keep interest expenses in check. In fourth-quarter 2017, the company’s interest and other expenses rose to nearly $12 million in comparison with $10 million in the prior-year quarter. Further, it anticipates interest and other expenses to rise around $45 million in 2018 from $38.2 million last year.
Nevertheless, Under Armour’s sustained focus on brand development, restructuring plans, expansion of direct-to-consumer and technology-based fitness businesses seem favorable. The company’s continuous efforts to innovate are also full of promise.
What Does the Zacks Model Say?
Our proven model does not conclusively show an earnings beat for Under Armour this quarter. This is because a stock needs to have both a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) and a positive Earnings ESP for this to happen.
Under Armour has an Earnings ESP of +7.22%. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
However, the company has a Zacks Rank #4 (Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Strong Sell) going into the earnings announcement.
Stocks With Favorable Combination
Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:
Michael Kors Holdings Limited has an Earnings ESP of +6.69% and a Zacks Rank #2.
Ralph Lauren Corporation (RL - Free Report) has an Earnings ESP of +2.92% and a Zacks Rank #2.
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Image: Bigstock
How is Under Armour (UAA) Stock Placed Ahead of Q1 Earnings?
Under Armour, Inc. (UAA - Free Report) is scheduled to report first-quarter 2018 results on May 1, before the opening bell.
The question lingering in investors’ minds is whether this marketer and distributor of apparel, footwear and accessories will be able to deliver a positive earnings surprise in the quarter to be reported. Let’s see how things are shaping up prior to this announcement.
What to Expect?
The Zacks Consensus Estimate for the quarter is pegged at a loss of 5 cents, wider than the loss of a penny reported a year ago. Analysts polled by Zacks expect revenues of $1.12 billion, almost flat with the year-ago quarter figure.
Under Armour, Inc. Price, Consensus and EPS Surprise
Under Armour, Inc. Price, Consensus and EPS Surprise | Under Armour, Inc. Quote
Factors at Play
For the first quarter, management expects revenues to decline or remain flat in comparison to the year-ago quarter. Further, the company envisions loss per share in the range 6-7 cents on the back of adjusted operating loss of nearly $15 million.
We believe that the prolonged weakness in the North American business is likely to tarnish first-quarter results. The company has been reporting sluggish sales from the region since fourth-quarter 2016. In fourth-quarter 2017, sales in North America declined 4.5%. The dismal show can be attributed to bankruptcies, store closures, decreased productivity and demand along with shift in fashion preference.
Additionally, gross margin has been consistently shrinking in the past few quarters. In fourth-quarter 2017, the metric contracted 140 basis points (bps) to 45% following a decline of 130, 190 and 70 bps in the third, second and first quarter, respectively. Management expectsgross margin to remain flat in the first quarter of 2018.
Further, Under Armour has been struggling to keep interest expenses in check. In fourth-quarter 2017, the company’s interest and other expenses rose to nearly $12 million in comparison with $10 million in the prior-year quarter. Further, it anticipates interest and other expenses to rise around $45 million in 2018 from $38.2 million last year.
Nevertheless, Under Armour’s sustained focus on brand development, restructuring plans, expansion of direct-to-consumer and technology-based fitness businesses seem favorable. The company’s continuous efforts to innovate are also full of promise.
What Does the Zacks Model Say?
Our proven model does not conclusively show an earnings beat for Under Armour this quarter. This is because a stock needs to have both a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) and a positive Earnings ESP for this to happen.
Under Armour has an Earnings ESP of +7.22%. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
However, the company has a Zacks Rank #4 (Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Strong Sell) going into the earnings announcement.
Stocks With Favorable Combination
Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:
Guess', Inc. (GES - Free Report) has an Earnings ESP of +16.18% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Michael Kors Holdings Limited has an Earnings ESP of +6.69% and a Zacks Rank #2.
Ralph Lauren Corporation (RL - Free Report) has an Earnings ESP of +2.92% and a Zacks Rank #2.
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>